Position in JAZZ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$35,245,236
-$59,849,371 QoQ
Shares Held
146,264
-70.9% QoQ
Ownership
0.225%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#68
of 640 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JAZZ Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $626,865,233 across 140 Biotechnology names. JAZZ ranks #5 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
369,451 | $230,367,476 | |
| 2 | INCY |
Incyte Corp
|
1,431,426 | $162,266,451 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,096,682 | $59,670,467 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
72,465 | $35,995,539 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
This page
|
146,264 | $35,245,236 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
506,545 | $28,984,504 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
228,060 | $17,850,256 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
348,239 | $12,679,381 |
All Filings in JAZZ
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $35,245,236 | 146,264 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $95,094,607 | 503,013 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $110,004,280 | 647,084 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $71,164,092 | 539,940 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $77,953,523 | 734,579 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $104,870,125 | 844,705 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $272,713,212 | 2,214,480 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $233,891,702 | 2,099,378 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $194,346,044 | 1,820,913 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $155,790,484 | 1,293,726 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $125,915,838 | 1,023,706 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $103,401,979 | 798,841 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $84,831,307 | 684,289 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $69,952,471 | 478,046 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $54,238,682 | 340,460 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $369,879 | 2,775 | Shares | Sole | 2022-10-18 | |
| 2021-12-31 | $797,524 | 6,260 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $875,401 | 6,723 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,062,982 | 22,872 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $1,036,352 | 6,305 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $1,001,193 | 6,066 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||